Año: 2023
Journal Impact Factor (JIF): 4.30
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | SCIE | 26/132 | Q1 | T1 | D2 |
| PHARMACOLOGY & PHARMACY | SCIE | 69/354 | Q1 | T1 | D2 |
Año: 2023
Journal Citation Indicator (JCI): 1,060
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| INFECTIOUS DISEASES | 29/132 | Q1 | T1 | D3 | 78,41 |
| PHARMACOLOGY & PHARMACY | 74/354 | Q1 | T1 | D3 | 79,24 |
Año:
2023
CiteScore:
7,300
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 5/80 | Q1 | T1 | D1 |
| Pharmacology (medical) | 47/272 | Q1 | T1 | D2 |
| Infectious Diseases | 83/344 | Q1 | T1 | D3 |
| Biochemistry | 130/438 | Q2 | T1 | D3 |
| Microbiology | 60/182 | Q2 | T1 | D4 |
| Microbiology (medical) | 46/140 | Q2 | T1 | D4 |
SJR año:
2023
Factor de Impacto:
0,920
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 10/116 | Q1 | T1 | D1 |
| Pharmacology (medical) | 65/276 | Q1 | T1 | D3 |
| Infectious Diseases | 97/340 | Q2 | T1 | D3 |
| Biochemistry | 143/448 | Q2 | T1 | D4 |
| Microbiology | 59/178 | Q2 | T1 | D4 |
| Microbiology (medical) | 43/136 | Q2 | T1 | D4 |
| Agencia | Código de Proyecto |
|---|---|
| Fulbright Scholar Fellowship | - |
| Instituto de Salud Carlos III (MePRAM Project) | PMP22/00092 |
| Instituto de Salud Carlos III FEDER | - |
| Instituto de Salud Carlos III FEDER, Spanish Network for the Research in Infectious Diseases (REIPI) | RD16/0016/0006; CIBER CB21/13/00012; CB21/13/00084; CB21/13/00095 |
| Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion by NextGeneration European Union | - |
| ISCIII-Deputy General Directorate for Evaluation and Promotion of Research-European Regional Development Fund "A Way of Making Europe" | - |
| State Plan for R+D+I 2013-2016 (National Plan for Scientific Research, Technological Development and Innovation 2008-2011) | PI22/00323 |
| Xunta de Galicia Postdoctoral Grant | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Pacios, Olga | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 2 | Herrera-Espejo, Soraya | Hospital Universitario Virgen del Rocío (Spain) |
| 3 | Armán, Lucía | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 4 | Ibarguren-Quiles, Clara | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 5 | Blasco, Lucía | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); MEPRAM (Spain) |
| 6 | Bleriot, Inés | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 7 | Fernández-García, Laura | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 8 | Ortiz-Cartagena, Concha | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 9 | Paniagua, María | Hospital Universitario Virgen del Rocío; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Spain) |
| 10 | Barrio-Pujante, Antonio | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) (Spain) |
| 11 | Aracil, Belén | Centro Nacional de Microbiologia; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas; MEPRAM (Spain) |
| 12 | Cisneros, José Miguel | Hospital Universitario Virgen del Rocío; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas; MEPRAM (Spain) |
| 13 | Pachón-Ibáñez, María Eugenia | Hospital Universitario Virgen del Rocío; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas; MEPRAM (Spain) |
| 14 | Universidade da Coruña; Study Group on Mechanisms of Action and Resistance to Antimicrobials (GEMARA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); MEPRAM (Spain) |
